AR and prostate carcinoma: Herein, we present data showing that transcription of the AR gene in primary non-malignant and malignant breast tissues generates a diverse array of splice variants, particularly the C-terminal truncated variant AR-V7, which has been linked to ADT resistance in men with prostate cancer [27, 28, 30, 34].